{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:23:08Z","timestamp":1791400988643,"version":"4.3.3"},"reference-count":22,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Emily's Entourage","award":["R1022"],"award-info":[{"award-number":["R1022"]}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2023,9,23]]},"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1183\/13993003.00770-2023","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T11:30:29Z","timestamp":1697715029000},"page":"2300770","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Organoid-guided synergistic treatment of minimal function CFTR mutations with CFTR modulators, roflumilast and simvastatin: a personalised approach"],"prefix":"10.1183","volume":"63","author":[{"given":"Sacha","family":"Spelier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"de Winter-de Groot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Keijzer-Nieuwenhuijze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Liem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kors","family":"van der Ent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke S.","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"2024102103192806000_63.1.2300770.1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/ppul.25733","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"2024102103192806000_63.1.2300770.2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2475911"},{"key":"2024102103192806000_63.1.2300770.3","unstructured":"European Medicines Agency. Kaftrio EMA Approval . 2023. www.ema.europa.eu\/en\/medicines\/human\/EPAR\/kaftrio#assessment-history-section"},{"key":"2024102103192806000_63.1.2300770.4","unstructured":"US Food and Drug Administration. Kaftrio FDA Approval . 2023. www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=212273"},{"key":"2024102103192806000_63.1.2300770.5","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00495-2022"},{"key":"2024102103192806000_63.1.2300770.6","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jcf.2023.03.004","article-title":"FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypes","volume":"22","author":"de Poel","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2024102103192806000_63.1.2300770.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02437-2022"},{"key":"2024102103192806000_63.1.2300770.8","unstructured":"Ramalho AS , Cuyx S , Boon M , et al. The importance of CFTR mRNA testing to uncover other variants in CF genotype that affect CFTR expression. https:\/\/researchportal.vub.be\/en\/publications\/the-importance-of-cftr- mrna-testing-to-uncover-other-variants-in-"},{"key":"2024102103192806000_63.1.2300770.9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41586-023-05854-7","article-title":"CFTR function, pathology and pharmacology at single-molecule resolution","volume":"616","author":"Levring","year":"2023","journal-title":"Nature"},{"key":"2024102103192806000_63.1.2300770.10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcf.2006.10.013","article-title":"High incidence of the CFTR mutations 3272-26A\u2192G and L927P in Belgian cystic fibrosis patients, and identification of three new CFTR mutations (186-2A\u2192G, E588V, and 1671insTATCA)","volume":"6","author":"Storm","year":"2007","journal-title":"J Cyst Fibros"},{"key":"2024102103192806000_63.1.2300770.11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000472347","article-title":"Difference in frequencies of the cystic fibrosis alleles, \u0394F508 and W1282X, between carriers and patients","volume":"2","author":"Kalman","year":"1994","journal-title":"Eur J Hum Genet"},{"key":"2024102103192806000_63.1.2300770.12","first-page":"222","article-title":"Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease","volume":"50","author":"Shoshani","year":"1992","journal-title":"Am J Hum Genet"},{"key":"2024102103192806000_63.1.2300770.13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcf.2021.09.020","article-title":"Functional restoration of CFTR nonsense mutations in intestinal organoids","volume":"21","author":"de Poel","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2024102103192806000_63.1.2300770.14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molmed.2023.01.004","article-title":"Readthrough compounds for nonsense mutations: bridging the translational gap","volume":"29","author":"Spelier","year":"2023","journal-title":"Trends Mol Med"},{"key":"2024102103192806000_63.1.2300770.15","unstructured":"European Medicines Agency. Daxas EMA Approval . 2023. www.ema.europa.eu\/en\/medicines\/human\/EPAR\/daxas"},{"key":"2024102103192806000_63.1.2300770.16","unstructured":"European Medicines Agency. Simvastatin EMA Approval . 2023. www.ema.europa.eu\/en\/medicines\/human\/referrals\/simvastatin-vale"},{"key":"2024102103192806000_63.1.2300770.17","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1190"},{"key":"2024102103192806000_63.1.2300770.18","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S1569-1993(23)00492-7","article-title":"P117 A longitudinal study on the impact of elexacaftor\/tezacaftor\/ivacaftor treatment on quality of life in people with cystic fibrosis in the real world","volume":"22","author":"Sutharsan","year":"2023","journal-title":"J Cyst Fibros"},{"key":"2024102103192806000_63.1.2300770.19","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/jpm11121376","article-title":"Prediction of real-world long-term outcomes of people with CF homozygous for the F508del mutation treated with CFTR modulators","volume":"11","author":"Muilwijk","year":"2021","journal-title":"J Pers Med"},{"key":"2024102103192806000_63.1.2300770.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02529-2017"},{"key":"2024102103192806000_63.1.2300770.21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcf.2016.11.008","article-title":"Biological variability of the sweat chloride in diagnostic sweat tests: a retrospective analysis","volume":"16","author":"Vermeulen","year":"2017","journal-title":"J Cyst Fibros"},{"key":"2024102103192806000_63.1.2300770.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00770-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:17:03Z","timestamp":1740363423000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00770-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,25]]},"published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1183\/13993003.00770-2023"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00770-2023","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]}}}